The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

PET/CT Theranostics with Lu-177 DOTATATE

Theranostic approach combining Ga-68 DOTATATE PET/CT for somatostatin receptor imaging and Lu-177 DOTATATE peptide receptor radionuclide therapy in metastatic neuroendocrine tumors.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Radyoloji department. Book Appointment →

What is PET/CT Theranostics with Lu-177 DOTATATE?

Theranostics is a precision oncology approach where a diagnostic imaging tracer (Ga-68 DOTATATE PET/CT) and a therapeutic radionuclide (Lu-177 DOTATATE) bind to the same molecular target — somatostatin receptor 2 (SSTR2) — for both visualization and treatment of neuroendocrine tumors (NETs).

Lu-177 DOTATATE peptide receptor radionuclide therapy (PRRT, brand name Lutathera) is FDA-approved for metastatic somatostatin receptor-positive gastroenteropancreatic NETs (GEP-NETs). Lu-177 emits beta particles delivering targeted radiation to tumor cells.

Treatment consists of 4 cycles of 7.4 GBq (200 mCi) Lu-177 DOTATATE every 8 weeks with concurrent amino acid infusion to protect the kidneys. NETTER-1 trial showed 79% reduction in disease progression and significant improvement in quality of life vs octreotide alone.

Symptoms

Metastatic gastroenteropancreatic neuroendocrine tumor
Somatostatin receptor-positive disease on Ga-68 DOTATATE PET/CT
Progressive disease on long-acting somatostatin analog therapy
Carcinoid syndrome with refractory symptoms
Functional NETs (insulinoma, gastrinoma, glucagonoma) requiring tumor reduction
Inoperable or unresectable NET with metastases
Adequate organ function and performance status (ECOG 0-2)

Risk Factors

Pre-existing kidney dysfunction (relative contraindication)
Bone marrow suppression or hematologic disorders
Concurrent chemotherapy (radiation pneumonitis, hepatic toxicity risk)
Pregnancy or breastfeeding (absolute contraindication)
Severe hepatic impairment
Active infection or uncontrolled comorbidity
Inability to tolerate amino acid infusion (volume overload risk)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • New diagnosis of metastatic gastroenteropancreatic NET
  • Disease progression on octreotide or lanreotide
  • Need for somatostatin receptor imaging (Ga-68 DOTATATE PET/CT)
  • Refractory carcinoid syndrome despite optimized medical therapy
  • Functional NET with biochemical or imaging progression
  • Multidisciplinary tumor board referral for theranostics evaluation
  • Side effect monitoring during/after PRRT (cytopenias, renal function, fatigue)

Treatment Methods

01
Pre-therapy Ga-68 DOTATATE PET/CT to confirm somatostatin receptor positivity (Krenning score 3-4)
02
Baseline labs: CBC, comprehensive metabolic panel, kidney and liver function
03
Lu-177 DOTATATE 7.4 GBq IV infusion over 30-40 minutes
04
Concurrent amino acid solution (lysine + arginine) for renal protection
05
Antiemetic prophylaxis and hydration
06
4 cycles every 8 weeks (total 29.6 GBq cumulative dose)
07
Post-therapy SPECT/CT imaging and laboratory monitoring

Which Department to Visit?

You can visit our Radyoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Radyoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

What Is MRI (Magnetic Resonance Imaging)?

Radyoloji

MRI uses a magnetic field and radio waves and is the gold standard for imaging the brain, spine, joints, and internal organs.

What Is CT (Computed Tomography)?

Radyoloji

Computed tomography provides rapid, detailed cross-sectional images in emergency, trauma, and oncology cases.

What Is Ultrasound (Ultrasonography)?

Radyoloji

Ultrasonography is radiation-free and is widely used in pregnancy follow-up and the evaluation of abdominal organs and superficial tissues.

What Is an X-ray (Plain Radiograph)?

Radyoloji

X-ray is the oldest and most widely used radiologic test, providing rapid diagnosis in bone and lung pathologies.

Mammography

Radyoloji

Mammography is specialized low-dose X-ray imaging of breast tissue that detects cancer, often before clinical palpation, and is the primary tool for breast cancer screening in women 40 and older per ACR/ESR guidelines.

Doppler Ultrasound

Radyoloji

Doppler USG is critical for evaluating deep vein thrombosis, carotid stenosis, and organ blood flow.

Angiography

Radyoloji

Angiography examines all vascular systems in the body in detail, especially the cardiac and cerebral vessels.

PET-CT (Positron Emission Tomography)

Radyoloji

PET-CT combines metabolic activity with anatomical imaging in cancer staging and treatment-response evaluation.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.